

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 9.72484729 |
| 2 | negative regulation of cell killing (GO:0031342) | 9.72484729 |
| 3 | negative T cell selection (GO:0043383) | 8.05243854 |
| 4 | negative thymic T cell selection (GO:0045060) | 7.72220848 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.40112503 |
| 6 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.93192102 |
| 7 | interferon-gamma production (GO:0032609) | 6.69107962 |
| 8 | positive thymic T cell selection (GO:0045059) | 6.59970227 |
| 9 | cellular response to interleukin-15 (GO:0071350) | 6.56657647 |
| 10 | response to interleukin-15 (GO:0070672) | 6.33981132 |
| 11 | thymic T cell selection (GO:0045061) | 6.33672515 |
| 12 | positive T cell selection (GO:0043368) | 6.23619299 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.90713192 |
| 14 | T cell selection (GO:0045058) | 5.82156968 |
| 15 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.79943691 |
| 16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.79069681 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.72914416 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.72914416 |
| 19 | T cell migration (GO:0072678) | 5.52446514 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 5.42552114 |
| 21 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 5.35092846 |
| 22 | regulation of alpha-beta T cell proliferation (GO:0046640) | 5.17020325 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.10762597 |
| 24 | T cell costimulation (GO:0031295) | 4.97904000 |
| 25 | negative regulation of T cell mediated immunity (GO:0002710) | 4.95514819 |
| 26 | lymphocyte costimulation (GO:0031294) | 4.92176211 |
| 27 | regulation of T cell tolerance induction (GO:0002664) | 4.91893172 |
| 28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.89849898 |
| 29 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.83844055 |
| 30 | T cell receptor signaling pathway (GO:0050852) | 4.81167856 |
| 31 | leukocyte aggregation (GO:0070486) | 4.75758546 |
| 32 | positive regulation of isotype switching (GO:0045830) | 4.73366804 |
| 33 | tolerance induction (GO:0002507) | 4.55188124 |
| 34 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.47739234 |
| 35 | positive regulation by symbiont of host defense response (GO:0052509) | 4.30464938 |
| 36 | modulation by symbiont of host defense response (GO:0052031) | 4.30464938 |
| 37 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.30464938 |
| 38 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.30464938 |
| 39 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.30464938 |
| 40 | modulation by symbiont of host immune response (GO:0052553) | 4.30464938 |
| 41 | activated T cell proliferation (GO:0050798) | 4.29870903 |
| 42 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.28437723 |
| 43 | B cell receptor signaling pathway (GO:0050853) | 4.26327547 |
| 44 | positive regulation of humoral immune response (GO:0002922) | 4.17847146 |
| 45 | * regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.15482092 |
| 46 | * regulation of natural killer cell mediated immunity (GO:0002715) | 4.15482092 |
| 47 | * positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.12223375 |
| 48 | * positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.12223375 |
| 49 | positive regulation of interleukin-2 production (GO:0032743) | 4.11766290 |
| 50 | positive regulation of DNA recombination (GO:0045911) | 4.11365265 |
| 51 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.08919443 |
| 52 | * regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.07757451 |
| 53 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.07263778 |
| 54 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.06919942 |
| 55 | neutrophil activation involved in immune response (GO:0002283) | 4.03331826 |
| 56 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.97865426 |
| 57 | regulation of isotype switching (GO:0045191) | 3.97255953 |
| 58 | natural killer cell activation (GO:0030101) | 3.90622854 |
| 59 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.89969416 |
| 60 | regulation of response to interferon-gamma (GO:0060330) | 3.86025760 |
| 61 | thrombin receptor signaling pathway (GO:0070493) | 3.83826042 |
| 62 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.79293605 |
| 63 | positive regulation of granulocyte differentiation (GO:0030854) | 3.78229738 |
| 64 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.77203450 |
| 65 | * positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.72505165 |
| 66 | * positive regulation of B cell mediated immunity (GO:0002714) | 3.72505165 |
| 67 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.71899653 |
| 68 | T-helper cell differentiation (GO:0042093) | 3.71899653 |
| 69 | * regulation of cell killing (GO:0031341) | 3.70374968 |
| 70 | cellular extravasation (GO:0045123) | 3.69524651 |
| 71 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.64763386 |
| 72 | * positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.63539912 |
| 73 | mast cell activation (GO:0045576) | 3.60546672 |
| 74 | lymphocyte migration (GO:0072676) | 3.57658585 |
| 75 | alpha-beta T cell activation (GO:0046631) | 3.56682610 |
| 76 | microglial cell activation (GO:0001774) | 3.56315440 |
| 77 | positive regulation of B cell differentiation (GO:0045579) | 3.54870987 |
| 78 | regulation of tolerance induction (GO:0002643) | 3.53754100 |
| 79 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.51811486 |
| 80 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.51811486 |
| 81 | T cell differentiation involved in immune response (GO:0002292) | 3.51811486 |
| 82 | regulation of T-helper 1 type immune response (GO:0002825) | 3.50838596 |
| 83 | sequestering of actin monomers (GO:0042989) | 3.50026406 |
| 84 | positive regulation of tolerance induction (GO:0002645) | 3.46590701 |
| 85 | alpha-beta T cell differentiation (GO:0046632) | 3.46382323 |
| 86 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.44042737 |
| 87 | positive regulation of defense response to virus by host (GO:0002230) | 3.42253640 |
| 88 | regulation of B cell differentiation (GO:0045577) | 3.41955290 |
| 89 | T cell differentiation (GO:0030217) | 3.41211453 |
| 90 | * regulation of immunoglobulin mediated immune response (GO:0002889) | 3.38575305 |
| 91 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.37827142 |
| 92 | leukocyte cell-cell adhesion (GO:0007159) | 3.35420993 |
| 93 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.32064336 |
| 94 | cytidine metabolic process (GO:0046087) | 3.30692525 |
| 95 | cytidine catabolic process (GO:0006216) | 3.30692525 |
| 96 | cytidine deamination (GO:0009972) | 3.30692525 |
| 97 | positive regulation of immunoglobulin production (GO:0002639) | 3.30009819 |
| 98 | heterotypic cell-cell adhesion (GO:0034113) | 3.29497324 |
| 99 | * positive regulation of cell killing (GO:0031343) | 3.28887095 |
| 100 | * regulation of B cell mediated immunity (GO:0002712) | 3.27929706 |
| 101 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.27721975 |
| 102 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.27573413 |
| 103 | T cell activation (GO:0042110) | 3.26486925 |
| 104 | response to type I interferon (GO:0034340) | 3.26309401 |
| 105 | macrophage activation involved in immune response (GO:0002281) | 3.25286942 |
| 106 | negative regulation of interleukin-12 production (GO:0032695) | 3.24829114 |
| 107 | cellular response to type I interferon (GO:0071357) | 3.23969501 |
| 108 | type I interferon signaling pathway (GO:0060337) | 3.23969501 |
| 109 | regulation of regulatory T cell differentiation (GO:0045589) | 3.23660399 |
| 110 | neutrophil activation (GO:0042119) | 3.23460915 |
| 111 | T cell activation involved in immune response (GO:0002286) | 3.22593801 |
| 112 | myeloid cell activation involved in immune response (GO:0002275) | 3.22118624 |
| 113 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.22001488 |
| 114 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.21663088 |
| 115 | B cell homeostasis (GO:0001782) | 3.21255004 |
| 116 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.21165737 |
| 117 | positive regulation of interferon-gamma production (GO:0032729) | 3.20905033 |
| 118 | * regulation of lymphocyte mediated immunity (GO:0002706) | 3.19500905 |
| 119 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.18219616 |
| 120 | response to host immune response (GO:0052572) | 3.18219616 |
| 121 | T cell proliferation (GO:0042098) | 3.17790291 |
| 122 | immunoglobulin mediated immune response (GO:0016064) | 3.17217290 |
| 123 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.17054156 |
| 124 | * positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.16937478 |
| 125 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.16690158 |
| 126 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.15400256 |
| 127 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.15088604 |
| 128 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.14472375 |
| 129 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.13842315 |
| 130 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.04315092 |
| 131 | B cell mediated immunity (GO:0019724) | 3.02522350 |
| 132 | regulation of platelet aggregation (GO:0090330) | 3.02209703 |
| 133 | leukocyte degranulation (GO:0043299) | 2.99592807 |
| 134 | granulocyte activation (GO:0036230) | 2.96848989 |
| 135 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.95279245 |
| 136 | angiogenesis involved in wound healing (GO:0060055) | 2.91078241 |
| 137 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.87174194 |
| 138 | lymphocyte homeostasis (GO:0002260) | 2.85723755 |
| 139 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.85413292 |
| 140 | megakaryocyte development (GO:0035855) | 2.85218942 |
| 141 | negative regulation of B cell proliferation (GO:0030889) | 2.84358149 |
| 142 | defense response to protozoan (GO:0042832) | 2.82474732 |
| 143 | response to host (GO:0075136) | 2.79126039 |
| 144 | response to host defenses (GO:0052200) | 2.79126039 |
| 145 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.79126039 |
| 146 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.78425459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.40967891 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.87362518 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.11403278 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.73655825 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.62188377 |
| 6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.39854177 |
| 7 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.07649980 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.81825322 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.76619274 |
| 10 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.67442511 |
| 11 | * MYB_26560356_Chip-Seq_TH2_Human | 3.44876563 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.19321707 |
| 13 | * MAF_26560356_Chip-Seq_TH1_Human | 2.93016304 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.90956984 |
| 15 | * MYB_26560356_Chip-Seq_TH1_Human | 2.79696677 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.56894770 |
| 17 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.55023903 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.51552146 |
| 19 | UTX_26944678_Chip-Seq_JUKART_Human | 2.50390274 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.33417889 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.28566568 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.24277123 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22703968 |
| 24 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.15186636 |
| 25 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 2.13281587 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.10215895 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.04798850 |
| 28 | * MAF_26560356_Chip-Seq_TH2_Human | 2.02078358 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.01242714 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.95053674 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.93256237 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.90505264 |
| 33 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.89534899 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.87783558 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72350047 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.68564363 |
| 37 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.66785391 |
| 38 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.65918139 |
| 39 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.64544144 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.63306160 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.61204093 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57103891 |
| 43 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.55873121 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55834992 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.53238165 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51048037 |
| 47 | GATA1_19941826_ChIP-Seq_K562_Human | 1.50855991 |
| 48 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.49846064 |
| 49 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.48994399 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.45542519 |
| 51 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.43726923 |
| 52 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.38835685 |
| 53 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.38772129 |
| 54 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.37945752 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36808309 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.34458062 |
| 57 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.33885458 |
| 58 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.33466465 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.28373817 |
| 60 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27192693 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26759444 |
| 62 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26076125 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22837350 |
| 64 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22213829 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.19489241 |
| 66 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17548747 |
| 67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10127295 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09969498 |
| 69 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.02880964 |
| 70 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.00946719 |
| 71 | * GATA3_26560356_Chip-Seq_TH1_Human | 1.00371583 |
| 72 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.99401644 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96484904 |
| 74 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.96095618 |
| 75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96058220 |
| 76 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.95274529 |
| 77 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94618429 |
| 78 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94412250 |
| 79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94287907 |
| 80 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93416149 |
| 81 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91702797 |
| 82 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91307009 |
| 83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89621413 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89567973 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89351283 |
| 86 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.89171236 |
| 87 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.88043399 |
| 88 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87186114 |
| 89 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.87170382 |
| 90 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.86670500 |
| 91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85948151 |
| 92 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.85405383 |
| 93 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.84887129 |
| 94 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.84836245 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82733588 |
| 96 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82122088 |
| 97 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.81514554 |
| 98 | * IRF1_19129219_ChIP-ChIP_H3396_Human | 0.80847949 |
| 99 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.78839264 |
| 100 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.78820892 |
| 101 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76986634 |
| 102 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.76555644 |
| 103 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.76091839 |
| 104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75650145 |
| 105 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.74325284 |
| 106 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.74134652 |
| 107 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.73867390 |
| 108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.73690498 |
| 109 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73214244 |
| 110 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.72907097 |
| 111 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.71550656 |
| 112 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.71267324 |
| 113 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.69843395 |
| 114 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.69065887 |
| 115 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68890047 |
| 116 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.68057890 |
| 117 | GATA1_22025678_ChIP-Seq_K562_Human | 0.64678938 |
| 118 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.64439424 |
| 119 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64213556 |
| 120 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.63351253 |
| 121 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.63064655 |
| 122 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.62779698 |
| 123 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.60936536 |
| 124 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.60340872 |
| 125 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.59146797 |
| 126 | GATA2_19941826_ChIP-Seq_K562_Human | 0.55977868 |
| 127 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.54923085 |
| 128 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.54606373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.30280986 |
| 2 | MP0003763_abnormal_thymus_physiology | 5.16046285 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.92421297 |
| 4 | MP0009785_altered_susceptibility_to | 3.79640807 |
| 5 | MP0000685_abnormal_immune_system | 3.62421080 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.38456796 |
| 7 | MP0001800_abnormal_humoral_immune | 3.32754567 |
| 8 | MP0006082_CNS_inflammation | 3.15807590 |
| 9 | MP0009333_abnormal_splenocyte_physiolog | 3.02213072 |
| 10 | * MP0002420_abnormal_adaptive_immunity | 3.01153415 |
| 11 | * MP0001819_abnormal_immune_cell | 3.00713677 |
| 12 | * MP0002723_abnormal_immune_serum | 3.00651752 |
| 13 | MP0005025_abnormal_response_to | 2.97843217 |
| 14 | MP0002166_altered_tumor_susceptibility | 2.97424064 |
| 15 | * MP0005387_immune_system_phenotype | 2.96624606 |
| 16 | * MP0001790_abnormal_immune_system | 2.96624606 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.82013492 |
| 18 | MP0003724_increased_susceptibility_to | 2.79802221 |
| 19 | * MP0002398_abnormal_bone_marrow | 2.77307216 |
| 20 | MP0002006_tumorigenesis | 2.67594560 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.62960867 |
| 22 | MP0002405_respiratory_system_inflammati | 2.57668412 |
| 23 | MP0003436_decreased_susceptibility_to | 2.54593618 |
| 24 | * MP0000716_abnormal_immune_system | 2.48404932 |
| 25 | MP0000703_abnormal_thymus_morphology | 2.36205951 |
| 26 | MP0010155_abnormal_intestine_physiology | 2.32708147 |
| 27 | MP0002722_abnormal_immune_system | 2.25467616 |
| 28 | MP0002419_abnormal_innate_immunity | 2.23354058 |
| 29 | MP0000689_abnormal_spleen_morphology | 2.16778494 |
| 30 | MP0003866_abnormal_defecation | 2.07724771 |
| 31 | MP0004947_skin_inflammation | 2.00902748 |
| 32 | * MP0002429_abnormal_blood_cell | 2.00352864 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.93555855 |
| 34 | MP0008004_abnormal_stomach_pH | 1.75746832 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.75359740 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.70378694 |
| 37 | MP0001873_stomach_inflammation | 1.70001181 |
| 38 | * MP0000858_altered_metastatic_potential | 1.68007363 |
| 39 | MP0000569_abnormal_digit_pigmentation | 1.67523800 |
| 40 | MP0002933_joint_inflammation | 1.66551766 |
| 41 | * MP0003448_altered_tumor_morphology | 1.58055489 |
| 42 | MP0001853_heart_inflammation | 1.56609663 |
| 43 | MP0004510_myositis | 1.54678299 |
| 44 | MP0003303_peritoneal_inflammation | 1.45815287 |
| 45 | MP0004381_abnormal_hair_follicle | 1.44588681 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.41338601 |
| 47 | MP0005310_abnormal_salivary_gland | 1.36253328 |
| 48 | MP0008469_abnormal_protein_level | 1.33434019 |
| 49 | MP0002009_preneoplasia | 1.26956613 |
| 50 | MP0004130_abnormal_muscle_cell | 1.17685224 |
| 51 | MP0000015_abnormal_ear_pigmentation | 1.17558006 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.15934978 |
| 53 | MP0004808_abnormal_hematopoietic_stem | 1.10757753 |
| 54 | MP0005167_abnormal_blood-brain_barrier | 1.05853914 |
| 55 | MP0000490_abnormal_crypts_of | 1.05603116 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.05358195 |
| 57 | MP0003045_fibrosis | 1.05316250 |
| 58 | MP0001851_eye_inflammation | 1.04413156 |
| 59 | MP0005645_abnormal_hypothalamus_physiol | 1.03820457 |
| 60 | MP0002132_abnormal_respiratory_system | 1.03709382 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.02932260 |
| 62 | MP0008872_abnormal_physiological_respon | 1.02794736 |
| 63 | MP0009764_decreased_sensitivity_to | 1.00965898 |
| 64 | * MP0002019_abnormal_tumor_incidence | 0.98007969 |
| 65 | MP0003183_abnormal_peptide_metabolism | 0.97927058 |
| 66 | MP0003172_abnormal_lysosome_physiology | 0.96042885 |
| 67 | MP0001545_abnormal_hematopoietic_system | 0.91833022 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 0.91833022 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 0.91366744 |
| 70 | * MP0009763_increased_sensitivity_to | 0.86665254 |
| 71 | MP0003828_pulmonary_edema | 0.86504342 |
| 72 | MP0005174_abnormal_tail_pigmentation | 0.85767458 |
| 73 | MP0001348_abnormal_lacrimal_gland | 0.83403329 |
| 74 | MP0004883_abnormal_blood_vessel | 0.83220375 |
| 75 | MP0004142_abnormal_muscle_tone | 0.81881527 |
| 76 | MP0001986_abnormal_taste_sensitivity | 0.79945639 |
| 77 | MP0008877_abnormal_DNA_methylation | 0.79723555 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.78021148 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 0.77610578 |
| 80 | MP0008057_abnormal_DNA_replication | 0.75861970 |
| 81 | MP0003453_abnormal_keratinocyte_physiol | 0.73918549 |
| 82 | MP0000372_irregular_coat_pigmentation | 0.73916915 |
| 83 | MP0008874_decreased_physiological_sensi | 0.72789035 |
| 84 | MP0002138_abnormal_hepatobiliary_system | 0.72254376 |
| 85 | MP0005084_abnormal_gallbladder_morpholo | 0.70892644 |
| 86 | MP0002163_abnormal_gland_morphology | 0.68548666 |
| 87 | MP0005166_decreased_susceptibility_to | 0.67606033 |
| 88 | MP0000230_abnormal_systemic_arterial | 0.67496525 |
| 89 | MP0000343_altered_response_to | 0.66895897 |
| 90 | MP0005023_abnormal_wound_healing | 0.65826517 |
| 91 | MP0003646_muscle_fatigue | 0.65423250 |
| 92 | MP0002136_abnormal_kidney_physiology | 0.60692853 |
| 93 | MP0001919_abnormal_reproductive_system | 0.60117154 |
| 94 | MP0003091_abnormal_cell_migration | 0.59625739 |
| 95 | MP0008007_abnormal_cellular_replicative | 0.59181660 |
| 96 | MP0003693_abnormal_embryo_hatching | 0.59113327 |
| 97 | MP0002693_abnormal_pancreas_physiology | 0.58850411 |
| 98 | MP0004484_altered_response_of | 0.57710446 |
| 99 | MP0003638_abnormal_response/metabolism_ | 0.57527461 |
| 100 | MP0004084_abnormal_cardiac_muscle | 0.54996953 |
| 101 | MP0009642_abnormal_blood_homeostasis | 0.53301937 |
| 102 | MP0001765_abnormal_ion_homeostasis | 0.52999448 |
| 103 | MP0001881_abnormal_mammary_gland | 0.51686659 |
| 104 | MP0005379_endocrine/exocrine_gland_phen | 0.51642976 |
| 105 | MP0010352_gastrointestinal_tract_polyps | 0.51429942 |
| 106 | MP0000249_abnormal_blood_vessel | 0.51077914 |
| 107 | MP0005381_digestive/alimentary_phenotyp | 0.50729154 |
| 108 | MP0002822_catalepsy | 0.50206313 |
| 109 | MP0000609_abnormal_liver_physiology | 0.49410887 |
| 110 | MP0003795_abnormal_bone_structure | 0.49066936 |
| 111 | MP0003077_abnormal_cell_cycle | 0.48799327 |
| 112 | MP0000477_abnormal_intestine_morphology | 0.47922260 |
| 113 | MP0001191_abnormal_skin_condition | 0.46137291 |
| 114 | MP0001216_abnormal_epidermal_layer | 0.43146596 |
| 115 | MP0001243_abnormal_dermal_layer | 0.42897031 |
| 116 | MP0000604_amyloidosis | 0.42732059 |
| 117 | MP0005076_abnormal_cell_differentiation | 0.42219935 |
| 118 | MP0000627_abnormal_mammary_gland | 0.40547022 |
| 119 | MP0003943_abnormal_hepatobiliary_system | 0.40106257 |
| 120 | MP0005451_abnormal_body_composition | 0.38881974 |
| 121 | MP0003787_abnormal_imprinting | 0.37662964 |
| 122 | MP0000367_abnormal_coat/_hair | 0.37338039 |
| 123 | MP0000613_abnormal_salivary_gland | 0.35150308 |
| 124 | MP0005390_skeleton_phenotype | 0.34995064 |
| 125 | MP0002277_abnormal_respiratory_mucosa | 0.32978312 |
| 126 | MP0001663_abnormal_digestive_system | 0.32546742 |
| 127 | MP0000313_abnormal_cell_death | 0.31927538 |
| 128 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.30631847 |
| 129 | MP0000598_abnormal_liver_morphology | 0.30427509 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 8.22151591 |
| 2 | Abnormality of T cell number (HP:0011839) | 8.00769980 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 6.13605996 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.02436389 |
| 5 | Combined immunodeficiency (HP:0005387) | 5.87457228 |
| 6 | Abnormality of T cells (HP:0002843) | 5.49351586 |
| 7 | Myositis (HP:0100614) | 5.27974640 |
| 8 | Increased IgM level (HP:0003496) | 4.89304367 |
| 9 | Recurrent bronchitis (HP:0002837) | 4.81883749 |
| 10 | Menorrhagia (HP:0000132) | 4.75202485 |
| 11 | Increased mean platelet volume (HP:0011877) | 4.73038139 |
| 12 | IgG deficiency (HP:0004315) | 4.67083326 |
| 13 | Purpura (HP:0000979) | 4.64223536 |
| 14 | IgM deficiency (HP:0002850) | 4.43665248 |
| 15 | Thyroiditis (HP:0100646) | 4.35136169 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 4.23273127 |
| 17 | Optic neuritis (HP:0100653) | 4.23273127 |
| 18 | Stomatitis (HP:0010280) | 4.21904694 |
| 19 | Nasal polyposis (HP:0100582) | 4.20121585 |
| 20 | Recurrent fungal infections (HP:0002841) | 4.14923699 |
| 21 | Eczematoid dermatitis (HP:0000976) | 4.12304903 |
| 22 | Gastrointestinal infarctions (HP:0005244) | 4.11509603 |
| 23 | Abnormality of eosinophils (HP:0001879) | 4.08653449 |
| 24 | Recurrent viral infections (HP:0004429) | 3.96397684 |
| 25 | Chronic otitis media (HP:0000389) | 3.95255913 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.77258134 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.77258134 |
| 28 | Leukocytosis (HP:0001974) | 3.70575920 |
| 29 | Autoimmune hemolytic anemia (HP:0001890) | 3.68221703 |
| 30 | Pustule (HP:0200039) | 3.67301415 |
| 31 | Orchitis (HP:0100796) | 3.66203520 |
| 32 | Recurrent abscess formation (HP:0002722) | 3.62943776 |
| 33 | Vasculitis (HP:0002633) | 3.59414125 |
| 34 | Hemoptysis (HP:0002105) | 3.52855546 |
| 35 | Lymphopenia (HP:0001888) | 3.52780839 |
| 36 | Abnormality of the nasal mucosa (HP:0000433) | 3.52308651 |
| 37 | Joint swelling (HP:0001386) | 3.44753750 |
| 38 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.42072459 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 3.28071844 |
| 40 | Keratoconjunctivitis sicca (HP:0001097) | 3.26123765 |
| 41 | Mediastinal lymphadenopathy (HP:0100721) | 3.24380005 |
| 42 | Hypergammaglobulinemia (HP:0010702) | 3.24304659 |
| 43 | Encephalitis (HP:0002383) | 3.22831042 |
| 44 | Pulmonary infiltrates (HP:0002113) | 3.21131778 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 3.18720658 |
| 46 | Abnormality of B cell number (HP:0010975) | 3.13574056 |
| 47 | B lymphocytopenia (HP:0010976) | 3.13574056 |
| 48 | IgA deficiency (HP:0002720) | 3.13294963 |
| 49 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.08985579 |
| 50 | Meningitis (HP:0001287) | 3.08873322 |
| 51 | Chronic diarrhea (HP:0002028) | 3.07765116 |
| 52 | Obstructive lung disease (HP:0006536) | 3.01989338 |
| 53 | Chronic obstructive pulmonary disease (HP:0006510) | 3.01989338 |
| 54 | Panhypogammaglobulinemia (HP:0003139) | 2.98567900 |
| 55 | Abnormality of the fingertips (HP:0001211) | 2.96208790 |
| 56 | Arterial thrombosis (HP:0004420) | 2.95344363 |
| 57 | Keratoconjunctivitis (HP:0001096) | 2.94042216 |
| 58 | Eosinophilia (HP:0001880) | 2.93566240 |
| 59 | Recurrent sinusitis (HP:0011108) | 2.92360540 |
| 60 | Abnormal platelet function (HP:0011869) | 2.92134920 |
| 61 | Impaired platelet aggregation (HP:0003540) | 2.92134920 |
| 62 | Recurrent skin infections (HP:0001581) | 2.71739309 |
| 63 | Recurrent bacterial skin infections (HP:0005406) | 2.69667706 |
| 64 | Spontaneous hematomas (HP:0007420) | 2.68404489 |
| 65 | Bronchitis (HP:0012387) | 2.68248647 |
| 66 | Gangrene (HP:0100758) | 2.64079119 |
| 67 | Lymphoma (HP:0002665) | 2.63944379 |
| 68 | Granulocytopenia (HP:0001913) | 2.61852763 |
| 69 | Thrombocytosis (HP:0001894) | 2.57246944 |
| 70 | Pulmonary embolism (HP:0002204) | 2.55276384 |
| 71 | Hyperlipoproteinemia (HP:0010980) | 2.43898312 |
| 72 | Chest pain (HP:0100749) | 2.43013862 |
| 73 | Amaurosis fugax (HP:0100576) | 2.42340208 |
| 74 | Periodontitis (HP:0000704) | 2.38859613 |
| 75 | Anorexia (HP:0002039) | 2.38322668 |
| 76 | Abnormality of the prostate (HP:0008775) | 2.37820163 |
| 77 | Colitis (HP:0002583) | 2.34572615 |
| 78 | Basal cell carcinoma (HP:0002671) | 2.32414694 |
| 79 | Epistaxis (HP:0000421) | 2.32305827 |
| 80 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.30219700 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 2.26226620 |
| 82 | Inflammation of the large intestine (HP:0002037) | 2.25988370 |
| 83 | Gingival bleeding (HP:0000225) | 2.24832970 |
| 84 | Cheilitis (HP:0100825) | 2.22841776 |
| 85 | Gingivitis (HP:0000230) | 2.20709518 |
| 86 | Recurrent otitis media (HP:0000403) | 2.19757845 |
| 87 | Abnormal platelet volume (HP:0011876) | 2.18876476 |
| 88 | Agammaglobulinemia (HP:0004432) | 2.18664157 |
| 89 | Abnormality of macrophages (HP:0004311) | 2.17638097 |
| 90 | Increased IgE level (HP:0003212) | 2.12121767 |
| 91 | Hypoplasia of the thymus (HP:0000778) | 2.11152169 |
| 92 | Poikilocytosis (HP:0004447) | 2.10842437 |
| 93 | Chronic sinusitis (HP:0011109) | 2.07724880 |
| 94 | Petechiae (HP:0000967) | 2.07078989 |
| 95 | Glomerulopathy (HP:0100820) | 2.06098937 |
| 96 | Urticaria (HP:0001025) | 2.04969136 |
| 97 | Papilloma (HP:0012740) | 2.01359851 |
| 98 | Verrucae (HP:0200043) | 2.01359851 |
| 99 | Prolonged bleeding time (HP:0003010) | 1.99360681 |
| 100 | Abnormality of the pleura (HP:0002103) | 1.98517991 |
| 101 | Ureteral stenosis (HP:0000071) | 1.96488837 |
| 102 | Arthralgia (HP:0002829) | 1.94905386 |
| 103 | Skin ulcer (HP:0200042) | 1.94381840 |
| 104 | Keratitis (HP:0000491) | 1.94202106 |
| 105 | Abnormality of the endocardium (HP:0004306) | 1.91982844 |
| 106 | Bronchiectasis (HP:0002110) | 1.89215221 |
| 107 | Acute hepatic failure (HP:0006554) | 1.88832295 |
| 108 | Interstitial pulmonary disease (HP:0006530) | 1.88280857 |
| 109 | Vertigo (HP:0002321) | 1.87613483 |
| 110 | Gastrointestinal stroma tumor (HP:0100723) | 1.86717355 |
| 111 | Polyneuropathy (HP:0001271) | 1.86693708 |
| 112 | Increased density of long bones (HP:0006392) | 1.84608588 |
| 113 | Hemiplegia (HP:0002301) | 1.84232881 |
| 114 | Conjunctival telangiectasia (HP:0000524) | 1.81224138 |
| 115 | Tinnitus (HP:0000360) | 1.80408796 |
| 116 | Recurrent pneumonia (HP:0006532) | 1.76696139 |
| 117 | Restrictive lung disease (HP:0002091) | 1.75849128 |
| 118 | 3-Methylglutaconic aciduria (HP:0003535) | 1.75625741 |
| 119 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.75452372 |
| 120 | Abnormality of binocular vision (HP:0011514) | 1.74741516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.73992232 |
| 2 | MAP4K1 | 4.80872976 |
| 3 | ITK | 3.54781248 |
| 4 | JAK3 | 3.32736357 |
| 5 | MAP3K14 | 3.24206910 |
| 6 | IKBKE | 3.07115552 |
| 7 | FGFR4 | 2.97120457 |
| 8 | ZAP70 | 2.90644736 |
| 9 | JAK1 | 2.86640102 |
| 10 | TYK2 | 2.64353820 |
| 11 | TBK1 | 2.43377198 |
| 12 | NLK | 2.42181095 |
| 13 | MST4 | 2.32886357 |
| 14 | BLK | 2.23784415 |
| 15 | GRK6 | 2.09903166 |
| 16 | STK10 | 2.08698992 |
| 17 | FGFR3 | 2.03090882 |
| 18 | LCK | 1.92141100 |
| 19 | CSK | 1.88261095 |
| 20 | TEC | 1.84189998 |
| 21 | CAMKK2 | 1.64456686 |
| 22 | IRAK4 | 1.62684802 |
| 23 | PRPF4B | 1.61800890 |
| 24 | FRK | 1.59441193 |
| 25 | NME2 | 1.45853432 |
| 26 | SYK | 1.44006440 |
| 27 | IKBKB | 1.42549098 |
| 28 | BTK | 1.36065496 |
| 29 | HCK | 1.35370856 |
| 30 | PIK3CG | 1.30775897 |
| 31 | IRAK3 | 1.27353404 |
| 32 | PTK2B | 1.20938613 |
| 33 | PRKCQ | 1.20278572 |
| 34 | MAP3K13 | 1.17775273 |
| 35 | MATK | 1.16124298 |
| 36 | KDR | 1.16013986 |
| 37 | ACVR1B | 1.15670553 |
| 38 | TAOK3 | 1.13532442 |
| 39 | TSSK6 | 1.06394394 |
| 40 | MAP3K12 | 1.01719380 |
| 41 | CHUK | 1.01610044 |
| 42 | CLK1 | 1.00076962 |
| 43 | PIM1 | 0.98574532 |
| 44 | KIT | 0.96175272 |
| 45 | PRKCH | 0.93971495 |
| 46 | CAMKK1 | 0.90242869 |
| 47 | JAK2 | 0.88964103 |
| 48 | LRRK2 | 0.86863703 |
| 49 | NUAK1 | 0.82562366 |
| 50 | LYN | 0.81335016 |
| 51 | GRK5 | 0.79410278 |
| 52 | STK24 | 0.77244838 |
| 53 | EPHA3 | 0.74006819 |
| 54 | MAP3K10 | 0.73220873 |
| 55 | MAP2K3 | 0.73028630 |
| 56 | SGK2 | 0.71584199 |
| 57 | DMPK | 0.71034843 |
| 58 | NEK9 | 0.70997528 |
| 59 | PASK | 0.69550212 |
| 60 | TESK2 | 0.69029463 |
| 61 | STK3 | 0.68981576 |
| 62 | PRKD2 | 0.68650000 |
| 63 | TNIK | 0.67962071 |
| 64 | TNK2 | 0.67075725 |
| 65 | MARK3 | 0.64910797 |
| 66 | FES | 0.61294011 |
| 67 | DAPK2 | 0.60968883 |
| 68 | EPHB1 | 0.60567563 |
| 69 | EEF2K | 0.59247147 |
| 70 | TGFBR2 | 0.57929375 |
| 71 | IRAK1 | 0.56217803 |
| 72 | BMX | 0.56198499 |
| 73 | MAPK12 | 0.56020319 |
| 74 | TYRO3 | 0.53733733 |
| 75 | STK4 | 0.53655872 |
| 76 | STK38 | 0.53597426 |
| 77 | EIF2AK1 | 0.50759653 |
| 78 | BMPR1B | 0.50488131 |
| 79 | SIK3 | 0.49956228 |
| 80 | YES1 | 0.49220352 |
| 81 | RPS6KA4 | 0.48972861 |
| 82 | TLK1 | 0.48953504 |
| 83 | MAP3K11 | 0.48096040 |
| 84 | MAP3K5 | 0.47620134 |
| 85 | PIM2 | 0.46960491 |
| 86 | PDPK1 | 0.45145803 |
| 87 | MAP2K6 | 0.45100069 |
| 88 | MAP3K7 | 0.44140181 |
| 89 | IGF1R | 0.42148243 |
| 90 | SIK2 | 0.41263805 |
| 91 | HIPK2 | 0.41127698 |
| 92 | PKN2 | 0.40707079 |
| 93 | SGK3 | 0.39388298 |
| 94 | PDK1 | 0.38163158 |
| 95 | PDGFRB | 0.37855052 |
| 96 | INSR | 0.37236821 |
| 97 | FYN | 0.36673585 |
| 98 | ADRBK1 | 0.35035067 |
| 99 | MAPK7 | 0.34695278 |
| 100 | GRK1 | 0.34465929 |
| 101 | MELK | 0.34022365 |
| 102 | CDK6 | 0.33669137 |
| 103 | MAPK11 | 0.33305016 |
| 104 | TAOK2 | 0.32375208 |
| 105 | CDC42BPA | 0.32182338 |
| 106 | MAP3K1 | 0.32150034 |
| 107 | ALK | 0.31343275 |
| 108 | GRK7 | 0.30503833 |
| 109 | WNK1 | 0.29674997 |
| 110 | ILK | 0.28759039 |
| 111 | IRAK2 | 0.27694303 |
| 112 | RAF1 | 0.27294631 |
| 113 | STK11 | 0.26616077 |
| 114 | CDK4 | 0.26468742 |
| 115 | CDK12 | 0.25866581 |
| 116 | FGFR1 | 0.25286897 |
| 117 | ABL1 | 0.25022269 |
| 118 | BMPR2 | 0.25009700 |
| 119 | MAPK13 | 0.24854146 |
| 120 | ADRBK2 | 0.24645053 |
| 121 | MAPKAPK2 | 0.24251575 |
| 122 | RIPK4 | 0.24153852 |
| 123 | TTN | 0.23168996 |
| 124 | CSF1R | 0.22370674 |
| 125 | PRKCD | 0.22166660 |
| 126 | CDK9 | 0.21286608 |
| 127 | RPS6KA5 | 0.20542061 |
| 128 | EIF2AK2 | 0.20017730 |
| 129 | FGR | 0.19740511 |
| 130 | TRPM7 | 0.15508038 |
| 131 | MAPK3 | 0.15346464 |
| 132 | TAOK1 | 0.14890198 |
| 133 | TRIB3 | 0.14505905 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.33176429 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.77937914 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.77153436 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.44551873 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.31115418 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.30269136 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.12904505 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.94822815 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.73836134 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.61894349 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.54475960 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 2.28609694 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 2.14544042 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.08710332 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.05414367 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.00215257 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.99709964 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.82870174 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.75560868 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.58554622 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42995372 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42394320 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.40170527 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39238831 |
| 25 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.37953649 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31426438 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30633592 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.30139713 |
| 29 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.23924336 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.22856011 |
| 31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19831861 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.18834421 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.18377624 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.18328487 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.15780738 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.14467865 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13738542 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.01059544 |
| 39 | Asthma_Homo sapiens_hsa05310 | 0.99472309 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.99387562 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.99310621 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92504187 |
| 43 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.91598826 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 0.89794336 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 0.88734828 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 0.87589436 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.87363974 |
| 48 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85207156 |
| 49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80940873 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 0.78856392 |
| 51 | Pertussis_Homo sapiens_hsa05133 | 0.78553671 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77301117 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76104847 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.71633329 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69820263 |
| 56 | Ribosome_Homo sapiens_hsa03010 | 0.67756500 |
| 57 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.66433520 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65802936 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65172326 |
| 60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64103716 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63127976 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57752231 |
| 63 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57690254 |
| 64 | Colorectal cancer_Homo sapiens_hsa05210 | 0.56656755 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.56132539 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52831015 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49407366 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49194978 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48639539 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48492664 |
| 71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47846459 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.46565585 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46335879 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45638847 |
| 75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45123324 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44924263 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43479387 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42883520 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42817383 |
| 80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42770634 |
| 81 | Olfactory transduction_Homo sapiens_hsa04740 | 0.42387153 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42131885 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39868731 |
| 84 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.39541458 |
| 85 | Long-term depression_Homo sapiens_hsa04730 | 0.38314441 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37770233 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.37586885 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37356128 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37199115 |
| 90 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.35635982 |
| 91 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.35339081 |
| 92 | Morphine addiction_Homo sapiens_hsa05032 | 0.35296908 |
| 93 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34970711 |
| 94 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34613753 |
| 95 | RNA degradation_Homo sapiens_hsa03018 | 0.34082701 |
| 96 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.33786159 |
| 97 | Phototransduction_Homo sapiens_hsa04744 | 0.33716890 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.32377498 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30532862 |
| 100 | Proteasome_Homo sapiens_hsa03050 | 0.28772866 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28607916 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27435703 |
| 103 | Adherens junction_Homo sapiens_hsa04520 | 0.25660080 |
| 104 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.24861844 |
| 105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.24671593 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24621127 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24529164 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24398481 |
| 109 | Spliceosome_Homo sapiens_hsa03040 | 0.22747382 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21218544 |
| 111 | Base excision repair_Homo sapiens_hsa03410 | 0.18263710 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.17425903 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17119602 |
| 114 | Prostate cancer_Homo sapiens_hsa05215 | 0.14667924 |
| 115 | Other glycan degradation_Homo sapiens_hsa00511 | 0.12510629 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.10771036 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.10595065 |
| 118 | Lysosome_Homo sapiens_hsa04142 | 0.08950246 |
| 119 | Endometrial cancer_Homo sapiens_hsa05213 | 0.08821482 |
| 120 | DNA replication_Homo sapiens_hsa03030 | 0.08819072 |
| 121 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.07359389 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.05986839 |
| 123 | Pathways in cancer_Homo sapiens_hsa05200 | 0.04689082 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.04133198 |
| 125 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.03273234 |
| 126 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.02324254 |
| 127 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.02000940 |
| 128 | Insulin resistance_Homo sapiens_hsa04931 | 0.01453622 |
| 129 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0017396 |
| 130 | Non-homologous end-joining_Homo sapiens_hsa03450 | -0.0004878 |

